- ►diabetesjournals.org KK Koh, MJ Quon, SH Han, Y Lee, JY Ahn, SJ … - Diabetes Care, 2008 - Am Diabetes Assoc RESULTS—Simvastatin doses of 10, 20, 40, and 80 mg significantly reduced total
cholesterol (mean changes 27, 25, 37, and 38%), LDL cholesterol (39, 38, 52, and
54%), and apolipoprotein B levels (24, 30, 36, and 42%) and improved flow- ... Cited by 14 - Related articles - BL Direct - All 6 versions
KK Koh, MJ Quon, SJ Lee, SH Han, JY Ahn, J … - Diabetes care, 2007 - Am Diabetes Assoc Hypertension is characterized by endothelial dysfunction and frequently clusters
with metabolic disorders that are characterized by insulin resistance (1,2).
These comorbidities may be explained, in part, by reciprocal relationships ... Cited by 11 - Related articles - BL Direct - All 7 versions
- ►nih.gov KK Koh, MJ Quon, SH Han, Y Lee, SJ Kim, JB … - Atherosclerosis, 2009 - Elsevier Simvastatin and pravastatin therapy significantly changed lipoprotein levels and
improved flow-mediated dilation after 2 months when compared with baseline (P <
0.001) or placebo treatment (P < 0.001 by ANOVA). Simvastatin therapy ... Cited by 2 - Related articles - All 54 versions
KK Koh, MJ Quon, SH Han, Y Lee, JB Park, SJ … - International Journal of Cardiology, 2009 - Elsevier Atorvastatin combined with amlodipine or amlodipine alone significantly reduced
blood pressure to a greater extent than atorvastatin alone (all P < 0.001 by
ANOVA). Atorvastatin combined with amlodipine significantly reduced plasma ... Cited by 1 - Related articles - All 2 versions
S Sugiyama, H Fukushima, K Kugiyama, H … - Atherosclerosis, 2007 - Elsevier Reduced incidence of type-2 diabetes has been shown in patients treated with
pravastatin. Adiponectin can exhibit beneficial effects on glucose metabolism.
We investigated whether pravastatin could improve glucose tolerance ... Cited by 22 - Related articles - All 19 versions
- ►nih.gov S Devaraj, D Siegel, I Jialal - The American journal of cardiology, 2007 - Elsevier The metabolic syndrome (MS) is characterized by low-grade inflammation and
confers an increased risk for diabetes mellitus and cardiovascular disease.
Statins reduce cardiovascular events in patients with the MS and have ... Cited by 17 - Related articles - All 22 versions
[CITATION] Reciprocal relationships between abnormal metabolic parameters and endothelial …
SS Jick, BD Bradbury - British journal of clinical pharmacology, 2004 - pubmedcentral.nih.gov We identified a population of adults 30–79 years of age between 1 January 1991
and 31 March 2002, who were being treated with a statin or who were diagnosed
with hyperlipidaemia but were not being treated with a lipid-lowering drug. ... Cited by 10 - Related articles - BL Direct - All 6 versions
LH Chamberlain - FEBS letters, 2001 - Elsevier Lovastatin treatment caused down-regulation of the insulin-responsive glucose
transporter 4 (Glut4) and up-regulation of Glut1 in 3T3-L1 adipocytes. These
changes in protein expression were associated with a marked inhibition of ... Cited by 25 - Related articles - All 6 versions
A Lammert, J Kratzsch, J Selhorst, PM … - Experimental and clinical endocrinology & diabetes: …, 2008 - ncbi.nlm.nih.gov AIMS/HYPOTHESIS: To evaluate the potential effectiveness of 'carbohydrate days'
as a dietary intervention to overcome insulin resistance in type 2 diabetes.
MATERIALS AND METHODS: Patients (n=14) with uncontrolled type 2 diabetes ... Cited by 3 - Related articles - BL Direct - All 4 versions
